Abstract
Psoriasis is a chronic immune-mediated, hyperproliferative disease of the skin with several presentations, which are similar across races and ethnicities. Prevalence is generally less in populations with skin of color. Genetic and environmental factors play leading roles in the pathogenesis of psoriasis. While clinical features, histopathology, and treatment are similar across ethnicities, lesions in darker colored skin frequently demonstrate thicker plaques, less erythema, and more violaceous and gray colors. This chapter will review the epidemiology, etiopathogenesis, clinical presentations, differential diagnoses, and treatment of psoriasis in patients with skin of color.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34(3):J314–21.
Shah SK, Arthur A, Yang YC, Steven S, Alexis AF. A retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept. J Drugs Dermatol. 2011;10(8):866–72.
Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology, vol. 1. 3rd ed. China: Elsevier; 2012. p. 135–55.
Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, Rolstad T, Margolis DJ. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52(1):23–6.
Kelly AP, Taylor SC, editors. Dermatology for skin of color. New York: McGraw Hill; 2009. p. 139–45.
Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509.
McMichael AJ, Vachiramon V, Guzman-Sanchez DA, Camacho F. Psoriasis in African-Americans: a Caregivers’ survey. J Drugs Dermatol. 2012;11(4):478–82.
Yang HZ, Wang K, Jin HZ, Gao TW, Xiao SX, Xu IH, Wang BX, Zhang FR, Li CY, Liu XM, Tu CX, Ji SZ, Zhu XJ. Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial. Chin Med J. 2012;125(11):1845–51.
Tsai TF, Ho JC, Song M, Szapary P, Guzzo C, Shen YK, Li S, Kim KJ, Kim TY, Choi JH, Youn JI. Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL). J Dermatol Sci. 2011;63(3):154–63.
Syed ZU, Hamzavi IH. Role of phototherapy in patients with skin of color. Semin Cutan Med Surg. 2011;30(4):184–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Thorpe, R., Pandya, A.G. (2014). Psoriasis. In: Jackson-Richards, D., Pandya, A. (eds) Dermatology Atlas for Skin of Color. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54446-0_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-54446-0_25
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54445-3
Online ISBN: 978-3-642-54446-0
eBook Packages: MedicineMedicine (R0)